OriGene Technologies, Inc.
Search:    
About FL cDNA Clones RNAi Gene Expression Lysates and Proteins Antibodies Tissue Other Products Tech Support
orange


OriGene shRNA in recent publications
Mitogen-Activated Protein Kinase-Dependent Interleukin-1a Intracrine Signaling Is Modulated by YopP during Yersinia enterocolitica Infection Infect. Immun., Jan 2012; 80: 289 - 297. [IL1A]

ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype Carcinogenesis, Jan 2012; 10.1093/carcin/bgs007. [ETS1 ]

PNAS Plus: TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2 PNAS, Jan 2012; 109: E177 - E186. [SERPINB2 ]

Heparanase and Syndecan-1 Interplay Orchestrates Fibroblast Growth Factor-2-induced Epithelial-Mesenchymal Transition in Renal Tubular Cells J. Biol. Chem., Jan 2012; 287: 1478 - 1488. [HPSE ]

EGLN3 (Gene ID 112399) Human shRNA

divider

To view the shRNA sequence, please register your email:
Email:
Register To View
Specifications Related Products Product Manual FAQs
Catalog No. Description Vector Price Shipping
TF317746 EGLN3 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector (Gene ID = 112399). 5µg purified plasmid DNA per construct pRFP-C-RS $ 650 7-9 Days *
TR30014 HuSH shRNA RFP cloning vector (pRFP-C-RS) Included for free
TR30015 Non-effective 29-mer scrambled shRNA cassette in pRFP-C-RS Vector Included for free
Add to Shopping Cart

Also for EGLN3 (Locus ID 112399)
spacer
Register To View Sequence

Reference Data
RefSeq: NM_022073NM_033344
Synonyms: FLJ21620; HIFPH3; MGC125998; MGC125999; PHD3
Summary:
shRNA Design:
These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, align it with our published shRNA design sequences. If these do not align, please utilize our custom shRNA service.
Performance Guranteed:
OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples.

For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).
* Delivery time in business days.

 

pattern
Inc 5000 Healthcare Company Copyright © 2012 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436


Reproduction of any materials from this website is strictly forbidden without permission.